[go: up one dir, main page]

CY1124337T1 - Βελτιωμενες μεθοδοι για την ακυλιωση μεϋτανσινολης - Google Patents

Βελτιωμενες μεθοδοι για την ακυλιωση μεϋτανσινολης

Info

Publication number
CY1124337T1
CY1124337T1 CY20211100594T CY211100594T CY1124337T1 CY 1124337 T1 CY1124337 T1 CY 1124337T1 CY 20211100594 T CY20211100594 T CY 20211100594T CY 211100594 T CY211100594 T CY 211100594T CY 1124337 T1 CY1124337 T1 CY 1124337T1
Authority
CY
Cyprus
Prior art keywords
maytansinol
amino acid
metansinol
acelyation
improved methods
Prior art date
Application number
CY20211100594T
Other languages
English (en)
Inventor
Wayne C. Widdison
Robert Yongxin Zhao
Original Assignee
Immunogen, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunogen, Inc. filed Critical Immunogen, Inc.
Publication of CY1124337T1 publication Critical patent/CY1124337T1/el

Links

Classifications

    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01R—ELECTRICALLY-CONDUCTIVE CONNECTIONS; STRUCTURAL ASSOCIATIONS OF A PLURALITY OF MUTUALLY-INSULATED ELECTRICAL CONNECTING ELEMENTS; COUPLING DEVICES; CURRENT COLLECTORS
    • H01R12/00—Structural associations of a plurality of mutually-insulated electrical connecting elements, specially adapted for printed circuits, e.g. printed circuit boards [PCB], flat or ribbon cables, or like generally planar structures, e.g. terminal strips, terminal blocks; Coupling devices specially adapted for printed circuits, flat or ribbon cables, or like generally planar structures; Terminals specially adapted for contact with, or insertion into, printed circuits, flat or ribbon cables, or like generally planar structures
    • H01R12/50—Fixed connections
    • H01R12/51—Fixed connections for rigid printed circuits or like structures
    • H01R12/55—Fixed connections for rigid printed circuits or like structures characterised by the terminals
    • H01R12/58—Fixed connections for rigid printed circuits or like structures characterised by the terminals terminals for insertion into holes
    • H01R12/585—Terminals having a press fit or a compliant portion and a shank passing through a hole in the printed circuit board
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/16—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • H—ELECTRICITY
    • H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05K—PRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
    • H05K1/00—Printed circuits
    • H05K1/02—Details
    • H05K1/0201—Thermal arrangements, e.g. for cooling, heating or preventing overheating
    • H05K1/0203—Cooling of mounted components
    • H—ELECTRICITY
    • H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05K—PRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
    • H05K1/00—Printed circuits
    • H05K1/02—Details
    • H05K1/11—Printed elements for providing electric connections to or between printed circuits
    • H05K1/115—Via connections; Lands around holes or via connections
    • H05K1/116—Lands, clearance holes or other lay-out details concerning the surrounding of a via
    • H—ELECTRICITY
    • H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05K—PRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
    • H05K1/00—Printed circuits
    • H05K1/18—Printed circuits structurally associated with non-printed electric components
    • H05K1/181—Printed circuits structurally associated with non-printed electric components associated with surface mounted components

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microelectronics & Electronic Packaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyamides (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Αποκαλύπτεται μία μέθοδος παρασκευής ενός εστέρα αμινοξέος της μεϋτανσινόλης, δια αντίδρασης μεϋτανσινόλης με έναν Ν-καρβοξυανυδρίτη ενός αμινοξέος (NCA) παρουσία ενός ξηραντικού παράγοντα. Επίσης αποκαλύπτεται μία βελτιωμένη μέθοδος παρασκευής ενός εστέρα αμινοξέος Της μεϋτανσινόλης κατά την οποία προστίθεται ένα νουκλεόφιλο στο μείγμα της αντίδρασης μετά τη συμπλήρωση της αντίδρασης μεταξύ της μεϋτανσινόλης και ενός Ν-καρβοξυανυδρίτη ενός αμινοξέος.
CY20211100594T 2012-09-26 2021-07-02 Βελτιωμενες μεθοδοι για την ακυλιωση μεϋτανσινολης CY1124337T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261705731P 2012-09-26 2012-09-26
PCT/US2013/061839 WO2014052537A1 (en) 2012-09-26 2013-09-26 Improved methods for the acylation of maytansinol
EP13774881.0A EP2900676B1 (en) 2012-09-26 2013-09-26 Improved method for the acylation of maytansinol

Publications (1)

Publication Number Publication Date
CY1124337T1 true CY1124337T1 (el) 2022-07-22

Family

ID=49328648

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20191100302T CY1121415T1 (el) 2012-09-26 2019-03-13 Βελτιωμενη μεθοδος για την ακυλιωση μεϋτανσινολης
CY20211100594T CY1124337T1 (el) 2012-09-26 2021-07-02 Βελτιωμενες μεθοδοι για την ακυλιωση μεϋτανσινολης

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CY20191100302T CY1121415T1 (el) 2012-09-26 2019-03-13 Βελτιωμενη μεθοδος για την ακυλιωση μεϋτανσινολης

Country Status (27)

Country Link
US (9) US9012629B2 (el)
EP (3) EP3904358A1 (el)
JP (7) JP6517693B2 (el)
CN (2) CN104768955B (el)
AU (4) AU2013323572B2 (el)
BR (2) BR112015006505B1 (el)
CA (2) CA3133906C (el)
CY (2) CY1121415T1 (el)
DK (2) DK2900676T3 (el)
ES (2) ES2880754T3 (el)
HR (2) HRP20190473T1 (el)
HU (2) HUE055443T2 (el)
IL (2) IL237899A (el)
LT (2) LT3486248T (el)
MX (2) MX366701B (el)
MY (1) MY169250A (el)
NZ (2) NZ739573A (el)
PL (2) PL2900676T3 (el)
PT (2) PT3486248T (el)
RS (2) RS58493B1 (el)
RU (2) RU2648992C2 (el)
SG (1) SG11201501918UA (el)
SI (2) SI3486248T1 (el)
SM (2) SMT201900170T1 (el)
TR (1) TR201903625T4 (el)
WO (1) WO2014052537A1 (el)
ZA (1) ZA201501898B (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY169250A (en) 2012-09-26 2019-03-19 Immunogen Inc Improved methods for the acylation of maytansinol
CN105585579A (zh) * 2014-10-24 2016-05-18 南京联宁生物制药有限公司 一种化合物及其制备方法以及美登素dm1的制备方法
KR20170129769A (ko) * 2015-03-17 2017-11-27 리제너론 파아마슈티컬스, 인크. 아미노산 아실화 시약 및 이의 사용 방법
WO2018112334A1 (en) 2016-12-16 2018-06-21 Bluefin Biomedicine, Inc. Anti-cub domain-containing protein 1 (cdcp1) antibodies, antibody drug conjugates, and methods of use thereof
WO2020212256A1 (en) * 2019-04-18 2020-10-22 Indena S.P.A. Diasteroselective process for the preparation of thiol- or disulfide-containing maytansinoid esters and intermediates thereof
WO2021107133A1 (ja) 2019-11-29 2021-06-03 日本マイクロバイオファーマ株式会社 メイタンシノールの酵素的生産方法
TW202506651A (zh) 2023-04-28 2025-02-16 日商中外製藥股份有限公司 使用n-羧基胺基酸酐之含有醯胺基化合物的製造方法

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6034556B2 (ja) * 1977-03-31 1985-08-09 武田薬品工業株式会社 抗生物質ｃ−１５００３
US4151042A (en) 1977-03-31 1979-04-24 Takeda Chemical Industries, Ltd. Method for producing maytansinol and its derivatives
US4137230A (en) 1977-11-14 1979-01-30 Takeda Chemical Industries, Ltd. Method for the production of maytansinoids
US4265814A (en) 1978-03-24 1981-05-05 Takeda Chemical Industries Matansinol 3-n-hexadecanoate
JPS5562090A (en) 1978-10-27 1980-05-10 Takeda Chem Ind Ltd Novel maytansinoid compound and its preparation
JPS55164687A (en) 1979-06-11 1980-12-22 Takeda Chem Ind Ltd Novel maytansinoid compound and its preparation
JPS5566585A (en) 1978-11-14 1980-05-20 Takeda Chem Ind Ltd Novel maytansinoid compound and its preparation
JPS55162791A (en) 1979-06-05 1980-12-18 Takeda Chem Ind Ltd Antibiotic c-15003pnd and its preparation
JPS55164685A (en) 1979-06-08 1980-12-22 Takeda Chem Ind Ltd Novel maytansinoid compound and its preparation
JPS55164686A (en) 1979-06-11 1980-12-22 Takeda Chem Ind Ltd Novel maytansinoid compound and its preparation
US4309428A (en) 1979-07-30 1982-01-05 Takeda Chemical Industries, Ltd. Maytansinoids
JPS5622790A (en) * 1979-07-31 1981-03-03 Takeda Chem Ind Ltd Novel maytansinoid compound and its preparation
JPS5645483A (en) 1979-09-19 1981-04-25 Takeda Chem Ind Ltd C-15003phm and its preparation
JP3054741B2 (ja) * 1989-09-29 2000-06-19 武田薬品工業株式会社 Ｔａｎ―１３１３およびそのアシル誘導体
US5208020A (en) 1989-10-25 1993-05-04 Immunogen Inc. Cytotoxic agents comprising maytansinoids and their therapeutic use
EP2266607A3 (en) * 1999-10-01 2011-04-20 Immunogen, Inc. Immunoconjugates for treating cancer
US6441163B1 (en) 2001-05-31 2002-08-27 Immunogen, Inc. Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents
TWI298067B (en) * 2002-01-31 2008-06-21 Daiso Co Ltd New optically active compound, method for kinetic resolution of carbonic acid derivatives and catalyst thereof
US8088387B2 (en) 2003-10-10 2012-01-03 Immunogen Inc. Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates
EP1651162B1 (en) 2003-05-20 2015-10-21 ImmunoGen, Inc. Improved cytotoxic agents comprising new maytansinoids
JP2007503439A (ja) 2003-08-22 2007-02-22 アクティブバイオティクス インコーポレイティッド リファマイシンアナログおよびそれらの使用法
TR201808537T4 (tr) 2004-09-23 2018-07-23 Genentech Inc Sistein değiştirilmiş antikorlar ve konjugatlar.
DK1819359T3 (en) * 2004-12-09 2015-04-20 Janssen Biotech Inc ANTI-integrin immunoconjugates, processes for their preparation and their use
US7301019B2 (en) 2005-01-21 2007-11-27 Immunogen, Inc. Method for the preparation of maytansinoid esters
WO2007011721A1 (en) * 2005-07-15 2007-01-25 Kalypsys, Inc. Inhibitors of mitotic kinesin
EP1913002B9 (en) * 2005-08-09 2012-04-25 Millennium Pharmaceuticals, Inc. Method of acylating maytansinol with chiral amino acids
EP1960406A2 (en) * 2006-11-06 2008-08-27 TEVA Gyógyszergyár Zártkörüen Müködö Részvénytársaság Ascomycin and pimecrolimus having reduced levels of desmethylascomycin and 32-deoxy-32-epichloro-desmethylascomycin respectively, and methods for preparation thereof
JP2008288289A (ja) 2007-05-16 2008-11-27 Oki Electric Ind Co Ltd 電界効果トランジスタとその製造方法
WO2010141566A1 (en) 2009-06-03 2010-12-09 Immunogen, Inc. Conjugation methods
EP2480557A2 (en) * 2009-09-25 2012-08-01 Cadila Healthcare Limited Process for the preparation of rapamycin derivatives
CA2816426A1 (en) * 2010-11-17 2012-06-07 Genentech, Inc. Alaninyl maytansinol antibody conjugates
MY169250A (en) 2012-09-26 2019-03-19 Immunogen Inc Improved methods for the acylation of maytansinol

Also Published As

Publication number Publication date
BR112015006505B1 (pt) 2022-03-15
AU2020203823B2 (en) 2021-12-09
EP3486248A1 (en) 2019-05-22
EP2900676A1 (en) 2015-08-05
US9469655B2 (en) 2016-10-18
RU2765072C2 (ru) 2022-01-25
CN104768955B (zh) 2018-04-27
MX2019008652A (es) 2019-09-13
US10944190B2 (en) 2021-03-09
CA3133906A1 (en) 2014-04-03
US9012629B2 (en) 2015-04-21
CN104768955A (zh) 2015-07-08
LT3486248T (lt) 2021-08-25
US20180099980A1 (en) 2018-04-12
US20240145953A1 (en) 2024-05-02
TR201903625T4 (tr) 2019-04-22
MX390615B (es) 2025-03-20
RS62075B1 (sr) 2021-07-30
WO2014052537A1 (en) 2014-04-03
IL237899A (en) 2017-08-31
US20240313444A1 (en) 2024-09-19
US20190013604A1 (en) 2019-01-10
AU2018201392A1 (en) 2018-03-15
US9796731B2 (en) 2017-10-24
NZ739573A (en) 2019-11-29
US20170137440A1 (en) 2017-05-18
JP2024010055A (ja) 2024-01-23
AU2013323572B2 (en) 2017-12-07
MX366701B (es) 2019-07-22
RU2648992C2 (ru) 2018-03-29
SMT202100390T1 (it) 2021-09-14
CN108586487A (zh) 2018-09-28
HRP20211030T1 (hr) 2021-10-01
CY1121415T1 (el) 2020-05-29
HUE055443T2 (hu) 2021-11-29
US10461449B2 (en) 2019-10-29
LT2900676T (lt) 2019-03-25
AU2013323572A1 (en) 2015-04-02
AU2018201392B2 (en) 2020-03-12
EP2900676B1 (en) 2018-12-19
EP3904358A1 (en) 2021-11-03
CN108586487B (zh) 2021-11-05
RS58493B1 (sr) 2019-04-30
CA2884873C (en) 2021-11-23
CA3133906C (en) 2023-05-02
DK2900676T3 (en) 2019-04-08
DK3486248T3 (da) 2021-07-12
ES2880754T3 (es) 2021-11-25
US10100062B2 (en) 2018-10-16
JP2020180150A (ja) 2020-11-05
JP2022068367A (ja) 2022-05-09
RU2018109295A (ru) 2019-02-26
BR112015006505A2 (pt) 2017-07-04
US20150191488A1 (en) 2015-07-09
MX2015003745A (es) 2015-06-24
JP6517693B2 (ja) 2019-05-22
HUE043285T2 (hu) 2019-08-28
JP2016500657A (ja) 2016-01-14
PT3486248T (pt) 2021-07-12
NZ706019A (en) 2018-03-23
HK1212341A1 (en) 2016-06-10
SMT201900170T1 (it) 2019-05-10
PL2900676T3 (pl) 2019-06-28
JP2020117527A (ja) 2020-08-06
AU2020203823A1 (en) 2020-07-02
PL3486248T3 (pl) 2021-10-25
US20140142297A1 (en) 2014-05-22
AU2022201557A1 (en) 2022-03-31
PT2900676T (pt) 2019-03-29
US20250007192A1 (en) 2025-01-02
MY169250A (en) 2019-03-19
EP3486248B1 (en) 2021-04-07
SI3486248T1 (sl) 2021-10-29
BR122021022582B1 (pt) 2023-01-10
JP2025098242A (ja) 2025-07-01
HRP20190473T1 (hr) 2019-05-03
IL253988B (en) 2019-02-28
SG11201501918UA (en) 2015-05-28
US20200153130A1 (en) 2020-05-14
RU2018109295A3 (el) 2021-06-24
ZA201501898B (en) 2019-06-26
RU2015111635A (ru) 2016-11-20
CA2884873A1 (en) 2014-04-03
SI2900676T1 (sl) 2019-04-30
IL253988A0 (en) 2017-10-31
JP2018109044A (ja) 2018-07-12
JP6735000B1 (ja) 2020-08-05
ES2716561T3 (es) 2019-06-13

Similar Documents

Publication Publication Date Title
CY1124337T1 (el) Βελτιωμενες μεθοδοι για την ακυλιωση μεϋτανσινολης
CY1123208T1 (el) Κυκλικα παραγωγα εστερων βορονικου οξεος, μεθοδος για την παρασκευη και θεραπευτικες χρησεις αυτων
CY1121129T1 (el) Αναστολεις toy fgfr4 πυριμιδινης
MX2015000749A (es) Metodo para la degradacion de queratina y uso del hidrolisato de queratina producido.
EA201590583A1 (ru) Способ получения терапевтических наночастиц
UY34656A (es) Polimorfos de (s)?2?(1?(9h?purin?6?ilamino)propil)?5?fluor?3?fenilquinazolin?4(3h)?ona, composición y método de preparación
MX376235B (es) Antígenos asociados a próstata y regímenes de inmunoterapia basados en vacuna.
MX2015017858A (es) Composicion polimerica solida obtenida por la polimerización de un monómero con contenido de grupo ácido en presencia de un compuesto de polieter.
CR20140534A (es) Proceso para la preparación de treprostinil y derivado de los mismos
EA201790286A1 (ru) Способ получения кабозантиниба, меченного фтором-18, и его аналогов
BR112014018756A8 (pt) Processo para preparo de etil éster de ácido n-(4-ciclo-hexil-3-trifluorometil-benziloxi)-acetimídico
AR091154A1 (es) Aparato para procesar informacion, metodo para procesar informacion, programa y aparato para transmitir una tabla de informacion para aplicaciones
BR112014014607A2 (pt) iniciadores de polimerização aniônicos multivalentes estabilizados e métodos para preparação dos mesmos
EA201401080A1 (ru) Порошок никотинамида, способ и устройство для его получения
EA201500234A1 (ru) Способ получения бензоксазинонов
BR112015000911A2 (pt) iniciadores cooperativos, sondas e suas respectivas aplicações
BR112017004495A2 (pt) variantes de celobiohidrolase e polinucleotídeos codificando as mesmas
BR112017009876A2 (pt) processos e intermediários para a preparação de éteres de dialcano terminados em ácido alfa,ômega-dicarboxílico
EP4283304A3 (en) Methods of detecting anti-leptin neutralizing antibodies
UY34604A (es) Inhibidores de oxadiazol de la producción de leucotrienos para terapia de combinación
MX362371B (es) Proceso para preparar 2-metoximetil-1,4-bencenodiamina y sales de esta.
UY34770A (es) ?un proceso para la producción de ácido metacrílico y sus derivados y polímeros producidos a partir de estos?.
CY1119871T1 (el) Στερεη μορφη αλατος της aλφa-6-mpeg6-o- υδροξυκωδονης ως αγωνιστες οπιοειδων και χρησεις αυτων
TR201901398T4 (tr) Lakozamidi hazırlama işlemi.
AR099070A1 (es) Ácido (s)- 3-metil-abscísico y ésteres del mismo